From the Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, 1400 Pressler St, Houston, TX 77030 (K.M.E.); Liver Imaging Group, Department of Diagnostic Radiology (J.C.H., C.B.S.), and Department of Medicine, Division of Gastroenterology and Hepatology (Y.K.), University of California San Diego, San Diego, Calif; Department of Diagnostic Radiology, Baylor College of Medicine, Houston, Tex (M.M.A.); Department of Radiology, University of Ottawa, Ottawa, Ontario, Canada (A.Z.K.); Department of Radiology, Radio-Oncology and Nuclear Medicine, Université de Montréal, Montreal, Quebec, Canada (A.T.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (K.J.F.); Department of Radiology, Montefiore Medical Center, Bronx, NY (V.C.); Department of Radiology and Center for Advanced Magnetic Resonance Development, Duke University Medical Center, Durham, NC (M.R.B.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY (R.K.D.); Department of Diagnostic Radiology, Thomas Jefferson University, Philadelphia, Pa (D.G.M.); Department of Radiology, Stanford University Medical Center, Stanford, Calif (A.K.); and Department of Radiology, New York Presbyterian-Columbia University Medical Center, New York, NY (E.M.H.).
Radiographics. 2017 Nov-Dec;37(7):1994-2017. doi: 10.1148/rg.2017170098.
The Liver Imaging Reporting and Data System (LI-RADS) is a reporting system created for the standardized interpretation of liver imaging findings in patients who are at risk for hepatocellular carcinoma (HCC). This system was developed with the cooperative and ongoing efforts of an American College of Radiology-supported committee of diagnostic radiologists with expertise in liver imaging and valuable input from hepatobiliary surgeons, hepatologists, hepatopathologists, and interventional radiologists. In this article, the 2017 version of LI-RADS for computed tomography and magnetic resonance imaging is reviewed. Specific topics include the appropriate population for application of LI-RADS; technical recommendations for image optimization, including definitions of dynamic enhancement phases; diagnostic and treatment response categories; definitions of major and ancillary imaging features; criteria for distinguishing definite HCC from a malignancy that might be non-HCC; management options following LI-RADS categorization; and reporting. RSNA, 2017.
肝脏影像报告和数据系统(LI-RADS)是为在患有肝细胞癌(HCC)风险的患者中对肝脏影像学发现进行标准化解读而创建的报告系统。该系统是在美国放射学院支持的诊断放射学家委员会的合作和持续努力下开发的,该委员会在肝脏成像方面具有专业知识,并得到了肝胆外科医生、肝病学家、肝病理学家和介入放射学家的宝贵意见。本文回顾了 2017 年版的 CT 和 MRI 肝脏影像报告和数据系统。具体主题包括 LI-RADS 的适用人群;图像优化的技术建议,包括动态增强阶段的定义;诊断和治疗反应类别;主要和辅助成像特征的定义;区分明确 HCC 与可能不是 HCC 的恶性肿瘤的标准;LI-RADS 分类后的管理选择;以及报告。RSNA,2017 年。